CD8 cytotoxic T cells and the development of new tuberculosis vaccines

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 6, 2002, Pages 789-790

  Lalvani, Ajit ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; GAMMA INTERFERON;

ANTIGEN RECOGNITION; CYTOTOXIC T LYMPHOCYTE; EDITORIAL; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; INTERFERON PRODUCTION; PRIORITY JOURNAL; TUBERCULOSIS; VACCINE PRODUCTION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES; GENETIC VECTORS; HLA ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037106264     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2206002     Document Type: Editorial

References (12)

1. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-12017.
2. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-3698.
3. Lalvani A, Brookes R, Wilkinson RJ, Malin AS, Pathan AA, Andersen P, Dockrell H, Pasvol G, Hill AV. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998;95:270-275.
4. Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998;161:2400-2406.
5. Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, Flynn JL, Barnes PF, Southwood S, Celis E, et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci USA 2000;97:12210-12215.
6. Lalvani A, Hill A. Cytotoxic T-lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design. Clin Sci (Lond) 1998;95:531-538.
7. + T cells. Am J Respir Crit Care Med 2002;166:843-848.
8. Dillon DC, Alderson MR, Day CH, Lewinsohn DM, Coler R, Bement T, Campos-Neto A, Skeiky YA, Orme IM, Roberts A, et al. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun 1999;67:2941-2950.
9. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med 1997;186:859-865.
10. Wilkinson RJ, Zhu X, Wilkinson KA, Lalvani A, Ivanyi J, Pasvol G, Vordermeier HM. 38000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis. Immunology 1998;95:585-590.
11. Pathan AA, Wilkinson KA, Wilkinson RJ, Latif M, McShane H, Pasvol G, Hill AV, Lalvani A. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur J Immunol 2000;30:2713-2721.
12. Lewinsohn DM, Zhu L, Madison VJ, Dillon DC, Fling SP, Reed SG, Grabstein KH, Alderson MR. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol 2001;166:439-446.